Navigation Links
Pathogenica CSO Speaks at IBC Life Sciences Drug Discovery & Diagnostic Development Week
Date:8/2/2011

CAMBRIDGE, Mass., Aug. 2, 2011 /PRNewswire/ -- Pathogenica, Inc. announced that the Company's Chief Scientific Officer, Graeme Doran, Ph.D., is speaking today at the IBC Life Sciences Drug Discovery & Diagnostic Development Week, in San Francisco.

During the conference, the only event on the application of next generation sequencing technology for research, diagnostic development, and patient care, Dr. Doran will speak on "Next Generation Sequencing & Genomic Medicine." He will present the development of Pathogenica's next generation sequencing assays for clinical diagnostics for greater accuracy at reduced cost. He will focus on Pathogenica's Human Papillomavirus sequencing panel, and demonstration of HPV identification from ThinPrep clinical samples.

"This is a significant demonstration of the utility of our assay for clinical specimens in combination with NGS," said Yemi Adesokan, Ph.D., Pathogenica's CEO. "Our work so far demonstrates that NGS can be applied to routine HPV screening specimens to precisely identify viral sub-types relevant to therapeutic decision-making. The Pathogenica DxSeq probe panels achieve comprehensive coverage of >30 high and low risk HPV strains from a single assay."

The Pathogenica test identified the presence of several HPV sub-types amongst the samples tested (HPV 16, 18, 31, 45, 51, 52, 56, 58, 67, 68, 97), and was able to identify multiple strains infecting a single individual. HPV plays a causative role in a number of cancers, and multiple infections may be of clinical significance and correlate with higher-grade lesions. Sequencing's ability to rapidly identify and quantify multiple infections is a significant advantage for clinicians to understand the impact of these viral subtypes.

In his talk, Dr. Doran will also preview forthcoming clinical applications of next generation sequencing for viral and bacterial genotyping.

Dr. Doran received undergraduate and D.Phil degrees from the University of Oxford, and has worked as a postdoctoral scientist on non-coding RNA biology and RNA sequencing at the David H. Koch Center for Integrative Cancer Research at MIT, and the Department of Pathology, Harvard Medical School. He has contributed book chapters, multiple peer-reviewed publications, presentations at international conferences, and currently serves as associate editor for the Journal of RNAi and Gene Silencing, and the Journal of Molecular and Genetic Medicine. He joined Pathogenica in 2010.

Pathogenica is preparing for CLIA approval and a commercial launch of its diagnostic tests in 2012.

About Pathogenica

Pathogenica, based in Cambridge, MA, was founded in 2009 to pioneer commercial applications of pathogen sequencing. Pathogenica applies next generation DNA sequencing technology for rapid multiplex identification of pathogens, drug resistance genes, and toxins in patient samples. The founding scientific advisory board (SAB) is comprised of distinguished scientists in the field, including George Church, Harvard Medical School; Ron Davis, Stanford University; W. Ian Lipkin, Columbia University; Andrew Onderdonk, Harvard Medical School; and Kun Zhang, University of California.

Pathogenica's high throughput pathogen detection system is expected to enable rapid and highly sensitive detection of a wide variety of pathogens from patient samples using just a common assay protocol. http://www.pathogenica.com

Contact:
Daniel Jackson
908-433-2628
djackson[at]pathogenica.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Pathogenica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. FMC Agricultural Products Executive Bob Trogele Speaks to the Iowa Agribusiness Showcase & Conference
2. Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India
3. Dr. Damien Bates of Organogenesis Speaks on Regenerative Medicine for Opening Night of TEDMED Conference
4. Patent Attorney John Rizvi Speaks at FIME International Medical Expo
5. Matthew Lehman of SPRI Clinical Trials Speaks On Designing Trials For Success At The Trout Group Investor Relations Seminar
6. Dr. Susan Weinschenk, Chief of Technical Staff and Services, Speaks on Neuro Web Design at Persuasive Technologies 2009 Conference and Voices That Matter Web Design Conference
7. Professor K. C. Nicolaou Speaks at WuXi AppTec
8. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
9. BioMed Realty Trust and BIND Biosciences Sign New Lease at Vassar Street Property
10. Neurocrine Biosciences Reports Second Quarter 2011 Results
11. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):